Omega-3 polyunsaturated fatty acids (PUFAs) exhibit neuroprotective properties and
represent a potential treatment for a variety of neurodegenerative and neurological …

Parkinson's disease (PD) is a neurodegenerative disease characterized by a progressive
loss of dopaminergic neurons from the nigrostriatal pathway, formation of Lewy bodies, and …

Atherosclerosis is an inflammatory chronic disease affecting arterial vessels and leading to
vascular diseases, such as stroke and myocardial infarction. The relationship between …

In recent decades, much conceptual thinking in trophic ecology has been guided by theories
of nutrient limitation and the flow of elements, such as carbon and nitrogen, within and …

Background & Objective: A number of neuropsychiatric disorders, including Parkinson's
disease, schizophrenia, attention deficit hyperactivity disorder, and, to some extent …

The bidirectional interaction between the gut microbiota (GM) and the Central Nervous
System, the so-called gut microbiota brain axis (GMBA), deeply affects brain function and …

The current research was performed to evaluate the effects of omega-3 fatty acids and
vitamin E co-supplementation on clinical signs and metabolic status in people with …

Abstract Arachidonic acid (AA 20: 4n-6) is an essential component of cell membranes and
modulates cell membrane fluidity. AA is metabolized by cyclo-oxygenase (COX) …

Polyunsaturated fatty acids (PUFAs) are lipid derivatives of omega-3 (docosahexaenoic
acid, DHA, and eicosapentaenoic acid, EPA) or of omega-6 (arachidonic acid, ARA) …

Parkinson's disease (PD) is characterized by dysfunction of the nigrostriatal system, loss of
dopamine neurons and intracellular aggregation of α-synuclein. Recently, both clinical and …